Pancreatic Cancer Epidermal Growth Factor Receptor ( EGFR ) Intron 1 Polymorphism Influences Postoperative Patient Survival and in vitro Erlotinib Response

By Tzeng Ching-Wei   Frolov Andrey   Frolova Natalya   Jhala Nirag   Howard J.   Vickers Selwyn   Buchsbaum Donald   Heslin Martin   Arnoletti J.  

Annals of Surgical Oncology, Vol. 14, Iss. 7, 2007-07 ,pp. : 2150-2158

Springer Publishing Company

Access to resources Recommend Favorite

The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy

By Magne N.   Pivot X.   Bensadoun R.-J.   Guardiola E.   Poissonnet G.   Dassonville O.   Francoual M.   Formento J.-L.   Demard F.   Schneider M.   Milano G.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2169-2177

Elsevier

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor and Prognosis in Colon Cancer: A Crack in the Wall?

By Ferrara Gerardo   Palombi Natalia   Di Blasi Arturo  

Annals of Surgical Oncology, Vol. 14, Iss. 7, 2007-07 ,pp. : 2169-2170

Springer Publishing Company

Access to resources Recommend Favorite

Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer

By Hayashi Naoki  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 523-531

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy

By          

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1118-1122

Spandidos Publications

Access to resources Recommend Favorite